TNXP
Tonix Pharmaceuticals Holding Corp
9.90$
+1.6%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
Tonix Pharmaceuticals Holding Corp (TNXP) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -100 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.0 | 0.0 | -1.2 | -2.6 | -5.7 | -8.5 | -23 | -43 | -37 | -19 | -24 | -27 | -49 | -76 | -98 | -102 | -61 | -100 | |
| – | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 0.2 | 0.1 | 0.1 | 0.0 | 0.0 | 0.1 | 1.3 | 4.3 | 3.4 | 1.9 | |
| – | – | 0.1 | 0.4 | 0.9 | 1.7 | 3.1 | 4.4 | 3.3 | 1.8 | 1.6 | 1.5 | 2.9 | 7.9 | 11 | 9.3 | 4.8 | 6.0 | |
| – | – | – | 0.4 | 2.0 | 1.8 | 3.1 | 4.4 | 3.4 | 1.8 | 1.6 | 1.5 | 4.2 | 11 | 11 | – | – | – | |
| 0.0 | 0.0 | 0.3 | 0.3 | 0.3 | 0.6 | 1.0 | 1.0 | -2.1 | 0.1 | 0.4 | 0.5 | -2.4 | 5.8 | 0.0 | 0.0 | 5.8 | 8.5 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.3 | 0.2 | 0.1 | 0.0 | 0.0 | 0.0 | 8.6 | 35 | 48 | 7.9 | 0.1 | 3.4 | |
| – | – | -0.1 | 0.0 | 0.0 | 0.0 | -0.4 | -24 | 17 | 7.2 | 0.0 | 0.0 | -8.6 | -35 | -48 | -29 | -0.1 | -4.5 | |
| – | – | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 3.3 | 2.5 | 0.5 | – | 6.7 | – | – | – | |
| – | – | – | 0.6 | 6.9 | 10 | 53 | 48 | 0.2 | 0.1 | 24 | 13 | 1.4 | 3.0 | -47 | -14 | 0.0 | -14 | |
| – | – | – | 2.0 | 0.6 | 0.3 | -0.3 | – | – | – | – | – | – | – | 0.0 | 8.9 | -2.4 | -9.7 | |
| 0.1 | – | 1.4 | 2.6 | 7.5 | 15 | 53 | 48 | 20 | 19 | 24 | 13 | 123 | 212 | 88 | 37 | 135 | 215 | |
| 0.0 | 0.0 | 0.1 | 0.0 | 1.7 | 6.4 | 30 | -19 | -0.2 | 6.6 | -0.5 | -14 | 66 | 102 | -58 | -95 | 74 | 110 | |
| 0.0 | 0.0 | -1.3 | -2.6 | -5.7 | -8.5 | -23 | -43 | -37 | -19 | -24 | -27 | -57 | -111 | -146 | -110 | -61 | -103 |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.